- 同
- intravenous immune globulin
WordNet
- the 4th letter of the Roman alphabet (同)d
- the 19th letter of the Roman alphabet (同)s
PrepTutorEJDIC
- deuteriumの化学記号
- sulfurの化学記号 / {略}South[ern]
- (おもに人称代名詞・固有名詞(人名),thereの後で)had, wouldの短縮形 / (疑問文でwhere,what,whenの後で)didの短縮形;Where'd he go?=Where did he go?
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Dawes JM1, Vincent A.
- Current opinion in supportive and palliative care.Curr Opin Support Palliat Care.2016 Jun;10(2):137-42. doi: 10.1097/SPC.0000000000000211.
- PURPOSE OF REVIEW: Over the last 20 years, several neurological conditions have been identified which appear to be caused directly by autoantibodies targeting receptors, ion channels and related proteins on neuronal or glial cells. Neuroimmune interactions are now accepted contributors to chronic pa
- PMID 27100817
- Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
- Zaja F1, Barcellini W2, Cantoni S3, Carpenedo M4, Caparrotti G5, Carrai V6, Di Renzo N7, Santoro C8, Di Nicola M9, Veneri D10, Simonetti F11, Liberati AM12, Ferla V2, Paoloni F13, Crea E13, Volpetti S1, Tuniz E1, Fanin R1.
- American journal of hematology.Am J Hematol.2016 May;91(5):E293-5. doi: 10.1002/ajh.24341. Epub 2016 Apr 4.
- In patients with immune thrombocytopenia (ITP) refractory to corticosteroids and intravenous immunoglobulins (IVIG), splenectomy may result at higher risk of peri-operative complications and, for this reason, potentially contraindicated. The thrombopoietin receptor agonists (TPO-RAs) romiplostim and
- PMID 26910388
- Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias.
- Dicke C1, Schneppenheim S2, Holstein K1, Spath B1, Bokemeyer C1, Dittmer R2, Budde U2, Langer F3.
- Annals of hematology.Ann Hematol.2016 May;95(6):945-57. doi: 10.1007/s00277-016-2650-x. Epub 2016 Apr 4.
- Acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder that may cause life-threatening hemorrhages in patients with plasma cell dyscrasias (PCDs). Early diagnosis and treatment require a thorough understanding of its underlying pathophysiology. Two patients with IgG MGUS presented with
- PMID 27040683
Related Links
- ニュース・更新情報 軽度から中等度のアルツハイマー病患者を対象としたGAMMAGARD S/DおよびGAMMAGARD LIQUID試験の結果を発表 2008年5月13日 この資料は、米バクスターインターナショナルインクが2008年4月17日(米国現地 ...
- KAWASAKI SYNDROME The recommended dose of GAMMAGARD S/D for patients with Kawasaki syndrome is either a single 1 g/kg dose or a dose of 400 mg/kg for four consecutive days beginning within seven days of the onset of ...
★リンクテーブル★
[★]
[★]